DrugDashboards
← Home
Manufacturing facility

InvaGen Pharmaceuticals, Inc

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
United States
Registered address
550 S Research Place, Central Islip, New York (NY) 11722, United States (USA)
Operations here
analysismanufacturepackrepack
FDA identifiers
FEI 3012696190 · DUNS 080334903

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2023-09-19
  • VAIDrug Quality Assurance2018-12-19
  • VAIDrug Quality Assurance2017-05-26

Drugs this plant is listed as making

56 distinct drugs across 185 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.